What's new

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

May 12, 2025 - 14:07
 0
Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Lexeo laid off 15% of staff in April to focus on lead cardiac gene therapies

Next Article

Regional power system planning could save Western states $3.25B: UC San Diego

Related Posts

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

PSUSA/00002643/202408

PSUSA/00002643/202408

May 12, 2025  0

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0